Web Stats Provided By Google Analytics

Wednesday, July 30, 2014

Eylea (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema

TARRYTOWN, N.Y. , July 29, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA A Injection for the treatment of Diabetic Macular Edema .

http://ift.tt/1uJ3Lvw?
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Tarrytown Roundup Posts